Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Cash Flow Quality Index
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Cash Flow Quality Index of -0.45x as of December 2025. Operating cash flow of CN¥-12.88 Million is below net income of CN¥28.63 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 301263 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Guangdong Taienkang Pharmaceutical Co. Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 301263 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)
Year-by-year earnings quality comparison for Guangdong Taienkang Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see market value of Guangdong Taienkang Pharmaceutical Co. L.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.45x | CN¥-12.88 Million | CN¥28.63 Million | ▼ -154.5% |
| 2024 | 0.83x | CN¥89.33 Million | CN¥108.22 Million | ▲ +41.4% |
| 2023 | 0.58x | CN¥93.53 Million | CN¥160.20 Million | ▼ -31.5% |
| 2022 | 0.85x | CN¥148.81 Million | CN¥174.61 Million | ▼ -14.7% |
| 2021 | 1.00x | CN¥120.02 Million | CN¥120.07 Million | ▲ +28.1% |
| 2020 | 0.78x | CN¥125.53 Million | CN¥160.83 Million | ▼ -43.2% |
| 2019 | 1.37x | CN¥75.44 Million | CN¥54.90 Million | — |